Navigation Links
Sanford Rose Associates® - Minneapolis Fills Key Management Position for the Micromedics Operation of Nordson Corporation
Date:3/3/2011

ST. PAUL, Minn., March 3, 2011 /PRNewswire/ -- Executive search firm Sanford Rose Associates® - Minneapolis announced today the successful completion of a key search engagement for Nordson Corporation: Lise W. Duran as General Manager of the company's Micromedics operation, a leading provider of biomaterial applicators used in a wide variety of medical procedures. Dr. Duran joins Micromedics with over 20 years of experience in the medical device industry, having held several positions of increasing responsibility at SurModics, Inc. She holds a Ph.D. in Cellular Immunology from the Uniformed Services University of the Health Sciences in Bethesda, Maryland.

John H. Wang, President and Managing Director of Sanford Rose Associates® - Minneapolis, said, "Lise's broad experience and proven ability to deliver results in the medical technology industry will be instrumental to the continued success of the Micromedics organization and to building Nordson's overall presence in this strategic and growing global market."

Micromedics, based in St. Paul, Minnesota, was acquired by Nordson in November 2010. The company is a leader in applying and dispensing biomaterials for controlling bleeding, healing wounds and other related medical procedures. Micromedics' FibriJet branded bioapplicator products enable the controlled dispense of a single material or simultaneous dispense of two materials to a localized treatment site with simple, one-handed operation. Nordson Corporation is one of the world's leading producers of precision dispensing equipment that applies adhesives, sealants, liquid and powder coatings and other materials to a broad range of consumer and industrial products during manufacturing operations. For further information on Micromedics and Nordson, visit http://www.micromedics.com and http://www.nordson.com, respectively.

Sanford Rose Associates® - Mi
'/>"/>

SOURCE Sanford Rose Associates
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Insmed to Present at Sanford C. Bernstein Biosimilars Long View Conference
2. Sanford Rose Associates Opens Minneapolis Office
3. Sanford Rose Associates Opens Wilmington, N.C. Office
4. Sanford Rose Associates Joins the International Executive Search Federation
5. Sanford Rose Associates(R)-Rochester Named Top Office
6. American Laser Centers Opens Three Minneapolis-St. Paul Area Clinics
7. Micromet, Inc. Fills Audit Committee Vacancy and Regains Compliance With NASDAQ Marketplace Rule
8. New Pleio Medication Adherence Service Increases Prescription Refills Up To 53%
9. RBC Life Sciences Fills Newly Created Vice President of Sales and Marketing Position With Industry Veteran
10. Darius Naigamwalla Appointed Senior Vice President and Head of the Brand Management Practice at Campbell Alliance
11. Milestone Biosciences, LLC Further Strengthens Executive Management Team
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... Diego , CA (PRWEB) , ... July 30, ... ... announced the successful completion of a field clinical study of its canine osteoarthritis ... developed together with Aratana Therapeutics (Kansas City, KS) and will be marketed in ...
(Date:7/30/2015)...  With over 60,000 customers across the globe, ISN improves the efficiency and effectiveness ... more than 60,000 safe and reliable contractors in over 80 countries. ... ... Over 60,000 Worldwide Customers In ... Headquartered in Dallas, TX , ISN has additional ...
(Date:7/30/2015)...  Discovery Laboratories, Inc. (Nasdaq: DSCO ) ... $1.0M tranche under a previously awarded Phase II ... up to $3.0 million to support continued development ... potential medical countermeasure to mitigate acute and chronic/late-phase ... initial $1.0 million under this grant in October ...
(Date:7/29/2015)... -- Sanofi, a global and diversified ... of 2015. CEO Olivier Brandicourt comments ... different businesses. Watch video interview and ... Topics covered in the interview include:  ... drivers - Diabetes - ...
Breaking Biology Technology:VetStem Biopharma Successfully Completes Large Milestone Efficacy Study for its Flagship Canine Osteoarthritis Stem Cell Product 2VetStem Biopharma Successfully Completes Large Milestone Efficacy Study for its Flagship Canine Osteoarthritis Stem Cell Product 3ISN Reaches Over 60,000 Worldwide Customers 2ISN Reaches Over 60,000 Worldwide Customers 3Discovery Labs Receives $1.0 million under an SBIR Grant in Continuing Support of the Development of Aerosolized KL4 Surfactant to Address Radiation-Induced Lung Injury 2Discovery Labs Receives $1.0 million under an SBIR Grant in Continuing Support of the Development of Aerosolized KL4 Surfactant to Address Radiation-Induced Lung Injury 3
... ANDS ) today announced that patient dosing has ... oral TLR7 agonist prodrug, in,patients with advanced solid tumors. ... to identify pharmacologically active doses,and preliminary antitumor activity as ... II trials., The Phase I trial is a ...
... Co., Ltd. (President:,Dr. Yuzuru Matsuda) announced that Kyowa ... U.S. subsidiary, received on February 25,2008 (local time) ... and Drug,Administration (FDA) for istradefylline (KW-6002), its investigational ... the not approvable letter FDA expressed concern if ...
... at North Carolina State University have demonstrated that ... chemically different so-called Janus particles will ... field is applied to liquid surrounding the particles. ... the Feb. 8, 2008, edition of Physical Review ...
Cached Biology Technology:Anadys Pharmaceuticals Commences Phase I Clinical Trial of ANA773 in Cancer Patients 2Anadys Pharmaceuticals Commences Phase I Clinical Trial of ANA773 in Cancer Patients 3Anadys Pharmaceuticals Commences Phase I Clinical Trial of ANA773 in Cancer Patients 4Kyowa Hakko Receives Not Approvable Letter from FDA for Istradefylline (KW-6002) 2'2-faced' particles act like tiny submarines 2
(Date:7/2/2015)... Sweden , July 2, 2015 ... sensors FPC1025, FPC1035, FPC1145 and FPC1155 from the distributor World ... one of FPC,s distributors in Asia . ... 2015. The sensors will be used by smartphone manufacturers in ... MSEK is included in the communicated revenue guidance of approximately ...
(Date:6/29/2015)... June 24, 2015 Research ... the "Latin America Biomedical Sensors Market - Growth, ... The Latin America Biomedical Sensors market is ... of 2.04% over the period 2014-2020 The ... to the genetic formulation of each individual. These sensors ...
(Date:6/25/2015)... June 25, 2015  Imagine a tool specifically designed ... healthier, happier life. That,s exactly what USANA,s True ... The cutting-edge, portable health program provides a personalized approached ... help improve your lifestyle and nutrition. ... gala Wednesday night, USANA,s THA was honored with the ...
Breaking Biology News(10 mins):FPC Receives Order for Touch Fingerprint Sensors of 268 MSEK 2Latin America Biomedical Sensors Market Report 2015-2020 2@USANAinc's Personalized Nutrition Program Wins Industry Innovation Award 2
... CITY , Jan. 24, 2013 /PRNewswire-iReach/ -- Amiigo, ... has developed a new device for gesture recognition and ... that uses accelerometers and machine learning algorithms to automatically ... device knows if users are using the elliptical trainer ...
... than geologists previously thought, according to new research results. ... put very small samples of peridotite, rock derived from Earth,s ... found that the rock can and does liquify, at least ... deep as 250 kilometers down in the mantle beneath the ...
... leading experts will meet today in Brussels, Belgium, to ... research and the key findings of FLAVIOLA an ... health benefits and potential applications. Members of the FLAVIOLA ... researchers to review the outcomes of FLAVIOLA,s research and ...
Cached Biology News:Amiigo Unveils Fitness Tracker That Knows What Exercise You're Performing 2Magma in Earth's mantle forms deeper than once thought 2Magma in Earth's mantle forms deeper than once thought 3Recent breakthroughs in cocoa flavanol research discussed by European research consortium and expert panel 2